TrialAlzheimer's research & therapy2026

Safety, tolerability and immunogenicity of vaccine ALZ-101 in patients with early Alzheimer's disease: randomised, controlled trial.

Zsófia Lovró et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.